FDA Enforcement Class II Ongoing

CMV IgM EIA, in vitro diagnostic.

Recall: Z-0342-2023 · Reported December 7, 2022

Enforcement

Recall Number
Z-0342-2023
Event ID
91106
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Bio-Rad Laboratories, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
December 7, 2022
Initiation Date
October 19, 2022
Classification Date
November 30, 2022
Address
6565 185th Ave Ne, Redmond, WA, 98052-5039, United States

Description

CMV IgM EIA, in vitro diagnostic.

Reason

Due to an unusual increase in the positivity rate with human IgM antibodies to cytomegalovirus (CMV) Enzyme Immunoassay (EIA).

Code Info

Catalog Number: 25178 UDI-DI Code: 00847865010733 Lot Numbers: B02022 E10022 G05022

Distribution

U.S.: CA, CO, FL, GA, HI, IA, MA, MN, NC, NH, NJ, PA, TN, and TX O.U.S.: None

Quantity

180 kits